Trial Profile
A safety study of combination treatment with Avonex [interferon beta-1a] and Zocor [simvastatin] in relapsing remitting multiple sclerosis
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Interferon beta-1a (Primary) ; Simvastatin
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- 18 Dec 2005 New trial record.